Since Congress did not include new regulations for laboratory-developed tests (LDTs) in a year-end spending budget, it appears the Food and Drug Administration (FDA) will take steps of its own to increase the agency’s oversight of LDTs. “We are moving forward with rulemaking,” said Elizabeth Hillebrenner, Associate Director for Scientific and Regulatory Programs at the …
March 6, 2023, Intelligence: Late-Breaking Lab News Read More »
